Embody Insertional Achilles Tendinopathy

Terminated

• Conditions: Insertional Achilles Tendinopathy

• Registration Number: NCT05998785
• Lead Sponsor: Zimmer Biomet

Brief Summary

The primary objective of this study is to evaluate the long-term effects on ankle/Achilles tendon pain after repair of insertional Achilles tendinopathy (IAT) augmented with TAPESTRY Biointegrative Implant.

Detailed Description

This study is a prospective case series of patients who have had insertional Achilles tendinopathy repair augmented with the Tapestry Biointegrative Implant. The primary aim of the study is to describe patient reported pain 12 months after surgical repair with Tapestry. The secondary aims are to assess the proportion of study subjects that experience treatment-related adverse events post-surgery, treatment related serious adverse events resulting in second surgical intervention, quality of life and other patient reported outcomes at all follow up timepoints post-surgery, and tissue thickness measured with MRI at 6 months post-surgery.

Study Timeline

• Study Start: 2022-08-02
• Study First Submitted: 2023-08-11
• Study First Submitted QC: 2023-08-11
• Study First Posted: 2023-08-21
• Primary Completion: 2024-08-01
• Study Completion: 2024-08-01
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-17
• Last Update Posted: 2024-12-20

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• Adult, 21 years and older;

• Insertional Achilles tendonitis requiring surgery that has failed at least 2 weeks of conservative management, which consist of:

  1. Shoe modification; or
  2. Nonsteroidal anti-inflammatory drugs; or
  3. Physical Therapy with/without modalities.

• Chronic Achilles tendon pain lasting longer than 3 months;

• MRI of the ankle within 30 days prior to the study surgery;

• Ability and willingness to comply with prescribed post-operative rehabilitation program;

• Ability and willingness to comply with follow-up regimen;

• Able to understand the informed consent process, including regulatory requirements such as HIPAA authorization, and document informed consent prior to completion of any study-related procedures; and

• Ability to read, understand, and complete subject-reported outcomes in English.

Exclusion Criteria

• History of Achilles tendon rupture;
• Previous Achilles tendon surgery on the index ankle;
• Genetic collagen disease, hypersensitivity, or objection to using bovine-derived materials;
• History of auto-immune or immunodeficiency disorders;
• History of chronic inflammatory disorders;
• Oral steroid use in last 2 months or injectable steroid use in last 4 weeks;
• History of heavy smoking (> 1 pack per day) within last 6 months;
• Hypersensitivity to poly(D,L-lactide) materials;
• Metal implants, fillings, shrapnel, and/or screws;
• Females of child-bearing potential who are pregnant or plan to become pregnant during the course of the study;
• Currently involved in any injury litigation or worker's compensation claims relating to the index ankle;
• Enrolled, or plans to enroll, in another clinical trial during this studythat would affect the outcomes of this study; or
• History of non-compliance with medical treatment, physical therapy/rehabilitation, or clinical study participation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain/VAS	12 months post-surgery	Visual Analog Scale (VAS) survey

Secondary Outcome Measures

Name	Time	Method
Patient Satisfaction	1 week, 2 weeks, 4 weeks, 6 weeks, 10 weeks, 3 months, 6 moths and 12 months post-op	Patient Satisfaction Survey
SF-12	Baseline, 1 week, 2 weeks, 4 weeks, 6 weeks, 10 weeks, 3 months, 6 moths and 12 months post-op	12-item Short Form- Health Survey
Tissue Thickness	Baseline and 6 months post-op	MRI tissue thickness of the Achilles tendon at baseline and 6 months post-surgery. Tissue thickness will be measured by trained personnel per the EMBODY-002 MRI procedure manual.
Safety/Adverse Events	Surgery, 1 week, 2 weeks, 4 weeks, 6 weeks, 10 weeks, 3 months, 6 moths and 12 months post-op	* Procedure and/or treatment related adverse events; * Procedure and/or treatment related Serious Adverse Events (SAE); * Procedure and/or treatment related Serious Adverse Events (SAE) necessitating a second surgical intervention (SSI);
Return to Normal Activity	1 week, 2 weeks, 4 weeks, 6 weeks, 10 weeks, 3 months, 6 moths and 12 months post-op	Return to Normal Activity survey
AOFAS	Baseline, 1 week, 2 weeks, 4 weeks, 6 weeks, 10 weeks, 3 months, 6 moths and 12 months post-op	American Orthopedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot questionnaire

Trial Locations

Locations (2)

Utica Park Clinic; 🇺🇸 Tulsa, Oklahoma, United States

Weil Foot and Ankle Institute; 🇺🇸 Libertyville, Illinois, United States